When was ReShape founded?

ReShape was founded in 2005 and raised its 1st funding round 2 years after it was founded.

Where is ReShape located?

ReShape is headquartered in San Clemente, United States.

How many employees does ReShape have?

As of Aug 31, 2026, the latest employee count at ReShape is 2.

Is ReShape a funded company?

ReShape is a funded company, having raised a total of $90.3M across 9 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Aug 31, 2007.

When was the latest funding round of ReShape?

ReShape's latest funding was a $***** Conventional Debt round on Feb 13, 2017, with participation from 0 investor. Its primary sector is Obesity. In United States, the Obesity sector has seen $340M in funding in 2026 to date.

Where does ReShape rank among its competitors?

ReShape ranks 4th amongst 19 active competitors, of which 7 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Nitinote Surgical, which secured $9.3M in Dec, 2024.

Who are the top competitors of ReShape?

ReShape's top competitors include Nitinote Surgical, Apollo Endo and USGI Medical. Among them, Nitinote Surgical secured the most recent funding round in December, 2024.

ReShape - 2026 Company Profile, Team, Funding & Competitors

Q: Is ReShape an acquired company?

ReShape got acquired by EnteroMedics on Oct 03, 2017.

Company Details

ReShape Medical has developed the ReShape Dual Balloon, a dual intra-gastric balloon system for weight loss. It is inserted into the stomach through an endoscopic procedure and filled with saline (salt water). The balloons remain in the stomach for six months and help reduce hunger. Insertion of the gastric balloon is completed in about 20 minutes, with no hospital stay required. The company has received FDA approval for its ReShape Integrated Dual Balloon system.

Website: reshapeready.com
Social
Phone Number: +1 **********

Key Metrics

Founded Year

2005

Location

San Clemente, United States

Stage

Acquired

Total Funding

$90.3M in 9 rounds

Latest Funding Round

Conventional Debt, Feb 13, 2017, $*****

Investors

USVP & 7 more

Ranked

4^th among 19 active competitors

Employee Count

2 as on Aug 31, 2026

Similar Companies

Nitinote Surgical & 28 more

Exit Details

Acquired by EnteroMedics (Oct 03, 2017)

View ReShape's full profile

ReShape got acquired by EnteroMedics on Oct 03, 2017 at an acquisition amount of $*****.

Click here to take a look at ReShape's acquisition in detail

ReShape has raised a total funding of $90.3M over 9 rounds. Its first funding round was on Aug 31, 2007. ReShape has 8 institutional investors.

Here is the list of recent funding rounds of ReShape:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Feb 13, 2017	8969514	Conventional Debt	1240642	9232073	2633999	9730585
Aug 26, 2015	9367036	Series D	4536287	4110144	1593734	Endeavour Vision & 4 more
Apr 21, 2015	3467625	Conventional Debt	3415281	1393679	3030286	Oxford Finance & 1 more

Access funding benchmarks and valuations. Sign up today!

View details of ReShape's funding rounds and investors

ReShape's employee count trend

ReShape has 2 employees as of Aug 26. Here is ReShape's employee count trend over the years:

Uncover ReShape's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of ReShape include Nitinote Surgical, Apollo Endo and USGI Medical. Here is the list of Top 10 competitors of ReShape, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Nitinote Surgical 2014, Ramat Gan (Israel), Series B	Developing non-surgical bariatric medical device	$26.1M	Accelmed, MTIP & 6 others	60/100
2nd	Apollo Endo 2005, Austin (United States), Acquired	Developer of therapeutic devices for obesity and other GI disorders	$80.4M	HIG BioHealth Partners, Novo Holdings & 9 others	58/100
3rd	USGI Medical 2001, San Clemente (United States), Series E	Incisionless surgical solutions improving patient lives through innovative endoluminal technologies	$45.9M	Alta Partners, InterWest Partners & 3 others	43/100
4th	ReShape 2005, San Clemente (United States), Acquired	A dual intra-gastric balloon system for weight loss	$90.3M	New Leaf Venture Partners, HealthCor Partners ... & 6 others	43/100
5th	Barosense 2001, Redwood City (United States), Series D	Restrictive oral and gastric implants to induce Satiety	$45.7M	Inovia Capital, Pappas Capital & 7 others	40/100
6th	Obalon 2008, Carlsbad (United States), Acqui-Hired	Weight loss solutions: LAP-BAND, ReShape Vest, Obalon balloon system	$63.6M	InterWest Partners, Amorepacific Ventures ... & 10 others	38/100
7th	BAROnova 2006, Goleta (United States), Series D	Satiety induction through endoscopically introduced Transpyloric shuttle	$77.8M	Longitude Capital, Delos Capital Partners ... & 8 others	35/100
8th	Vibrynt 2006, Palo Alto (United States), Deadpooled	Vibrynt: Stylish coat hooks and home storage solutions provider	$50.3M	New Enterprise Associates, Delphi Ventures ... & 1 others	35/100
9th	Satiety 2000, Palo Alto (United States), Deadpooled	Device for transoral gastroplasty, an endoscopic approach to satiety induction	$63.5M	Skyline Ventures, Venrock & 5 others	34/100
10th	Bfkw 2004, Grand Rapids (United States), Series A	Satiety induction through gastric implant	$12.4M	-	34/100